CA1025448A - Derives du benzo-1,3-dioxole - Google Patents

Derives du benzo-1,3-dioxole

Info

Publication number
CA1025448A
CA1025448A CA206,325A CA206325A CA1025448A CA 1025448 A CA1025448 A CA 1025448A CA 206325 A CA206325 A CA 206325A CA 1025448 A CA1025448 A CA 1025448A
Authority
CA
Canada
Prior art keywords
benzodioxole derivatives
benzodioxole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA206,325A
Other languages
English (en)
Inventor
Pietro Mennella
Aldo Salimbeni
Elso Manghisi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Luso Farmaco dItalia SpA
Original Assignee
Istituto Luso Farmaco dItalia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT2773673A external-priority patent/IT1044236B/it
Priority claimed from IT2481174A external-priority patent/IT1051359B/it
Application filed by Istituto Luso Farmaco dItalia SpA filed Critical Istituto Luso Farmaco dItalia SpA
Application granted granted Critical
Publication of CA1025448A publication Critical patent/CA1025448A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA206,325A 1973-08-09 1974-08-06 Derives du benzo-1,3-dioxole Expired CA1025448A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2773673A IT1044236B (it) 1973-08-09 1973-08-09 Eteri di benzodiossoli 2.2 disostituiti
IT2481174A IT1051359B (it) 1974-07-04 1974-07-04 Eteri di benzodiossoli 2.2 diso stituiti

Publications (1)

Publication Number Publication Date
CA1025448A true CA1025448A (fr) 1978-01-31

Family

ID=26328539

Family Applications (1)

Application Number Title Priority Date Filing Date
CA206,325A Expired CA1025448A (fr) 1973-08-09 1974-08-06 Derives du benzo-1,3-dioxole

Country Status (8)

Country Link
US (1) US3970672A (fr)
JP (1) JPS5521749B2 (fr)
BE (1) BE818710A (fr)
CA (1) CA1025448A (fr)
DE (1) DE2436721C3 (fr)
FR (1) FR2240004B1 (fr)
GB (1) GB1458321A (fr)
NL (1) NL158075B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4091222A (en) * 1973-08-09 1978-05-23 Elso Manghisi 2,2 Disubstituted-benzodioxoles
US4076833A (en) * 1973-12-17 1978-02-28 A. Christiaens Societe Anonyme Derivatives of 1,3-benzodioxole, the preparation and use thereof
FR2353291A1 (fr) * 1976-05-31 1977-12-30 Parcor Nouveaux derives du benzofuranne
AU1506499A (en) * 1997-12-12 1999-07-05 Toyama Chemical Co. Ltd. Alkyl ether derivatives or salts thereof and calcium antagonists containing the same
JP4549452B2 (ja) * 1997-12-12 2010-09-22 富山化学工業株式会社 アルキルエーテル誘導体またはその塩並びにそれらを含有するカルシウム拮抗剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA749380A (en) * 1966-12-27 Smith Kline And French Laboratories Limited 1:3-benzodioxole derivatives
US2683742A (en) * 1951-02-23 1954-07-13 Searle & Co Nu, nu-disubstituted omega-arylmethoxy-omega-arylalkylamine derivatives
GB1220056A (en) * 1967-02-21 1971-01-20 Fisons Pest Control Ltd Substituted benzodioxoles
US3787443A (en) * 1971-02-25 1974-01-22 Zoecon Corp Aryloxy epithio ethers
US3915969A (en) * 1972-04-11 1975-10-28 Luso Farmaco Inst 2,2-Disubstituted benzodioxoles

Also Published As

Publication number Publication date
AU7206674A (en) 1976-02-12
NL7410708A (nl) 1975-02-11
GB1458321A (en) 1976-12-15
DE2436721A1 (de) 1975-04-17
JPS5070369A (fr) 1975-06-11
FR2240004A1 (fr) 1975-03-07
NL158075B (nl) 1978-10-16
BE818710A (fr) 1974-12-02
DE2436721B2 (de) 1978-01-12
FR2240004B1 (fr) 1978-07-28
US3970672A (en) 1976-07-20
DE2436721C3 (de) 1978-09-21
JPS5521749B2 (fr) 1980-06-12

Similar Documents

Publication Publication Date Title
AU468242B2 (en) 2-cyclohexene-1-one derivatives
CA1012534A (en) 2,6-diaminonebularine derivatives
AU477010B2 (en) 1,3-oxygenated &-oestratrienes
CA1026760A (fr) Derives de la 3,-4-dihydro-2h-naphtaline-1-un-5-oxypropile-piperazine
GB1484291A (en) 1,3-benzo-dioxole derivatives
CA1025448A (fr) Derives du benzo-1,3-dioxole
CA1029726A (fr) Derives de naphtyridene-1,8 carboxami-detetrazolyl-3
CA1035359A (fr) Derives de tetrahydro-1,2,3,4 isoquinoline substitues en 1 et disubstitues en 6,7
AU503626B2 (en) Substituted 1, 5-diphenyl-3-formazancarbonitriles
CA1024140A (fr) Anilino-6 trihydroxyanthraquinones-1,4,5
CA1010882A (en) 5-bromo-5-nitro-2-alkylsubstituted-1,3-dioxane
AU469505B2 (en) 1,4-ethano-2,3-dihydroquinoline derivatives
AU487239B2 (en) 2, 3-methanoprostaglandin derivatives
AU477537B2 (en) 3, 4-DIHYDRO-2H-NAPHTHALIN-lone-5-OXYPROPYLPIPERAZINE DERIVATIVES
AU480736B2 (en) 1, 2-diphenyl-ethane derivatives
CA1018157A (en) 8,8'-dioxo-6,6'-azopurine
AU458655B2 (en) Benzenesulfonylurea derivatives
AU492554B2 (en) 6-alkyl-9,10-dihydro-2' b-methyl-5'-benzyl-ergopeptide derivatives
AU6650674A (en) 1, 2-diphenyl-ethane derivatives
AU478074B2 (en) 1,3-oxygenated s-oestratrienes
AU7582674A (en) 6-alkyl-9,10-dihydro-2' b-methyl-5'-benzyl-ergopeptide derivatives
AU489033B2 (en) HERDICIDAL l, 3, 4-THIADIAZOL-2-YL-UREAS
AU482390B2 (en) New derivatives of 2,benzamido-5-nitro-thiazoles
AU478031B2 (en) 5-bromo-5-nitro-2-alkylsubstituted-1, 3-dioxane
AU491359B2 (en) Amphetamine derivatives